The Acute Intermittent Porphyria Market Is Expected to Grow at a CAGR of 5.6 % by Forecasts Period 2018 to 2023
The Global Acute Intermittent Porphyria Market is segmented on the basis by diagnosis, by treatment, and by end user. On the basis of treatment, it is segmented into gonadotropin-releasing hormone analogues, prophylactic hematin infusions, and others.
View full press release